Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]

Documenti analoghi

• Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study
  di: Wang, Chen, et al.
  Pubblicazione: (2015)
• Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
  Pubblicazione: (2014)
• Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
  di: Vincken, Walter, et al.
  Pubblicazione: (2014)
• Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
  di: D'Urzo, Anthony, et al.
  Pubblicazione: (2011)
• Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
  di: Buhl R, et al.
  Pubblicazione: (2012-10-01)